Case Study

Novartis: Strategic position in the life sciences industry (A)

16 pages
March 2016
Reference: IMD-7-1742

This two-part case series examines the strategic positioning of Novartis – a leading Swiss multinational – in the life sciences industry during the last decade. Case A provides an introduction to Novartis and the major decisions taken by its longest-serving CEO, Daniel Vasella. It also offers an overview of the industry’s challenges in the period following the financial crisis of 2008/2009, and a profile of some of its major players. It concludes by placing the spotlight on the dilemma faced by the company’s newly appointed CEO Joe Jimenez: Should he pursue the strategy of his predecessor or not?

Learning Objective

Understand the concept of positioning in an industry and the five choices that every company has: product specialist, market specialist, product market specialist, generalist and hybrid. What are the factors behind a company’s decision to adopt a specific strategic position?

Marketing Strategy, Positioning, Diversification, Pharmaceuticals, Product, Pharmaceutical Marketing
Novartis, Healthcare, Pharmaceuticals
Published Sources
© 2016
Available Languages
Case clearing houses
IMD case studies are distributed through case clearing houses. In order to browse the collection and purchase copies please visit the links below.

The Case Centre

Cranfield University

Wharley End Beds MK43 0JR, UK
Tel +44 (0)1234 750903
Email [email protected]

Harvard Business School Publishing

60 Harvard Way, Boston MA 02163, USA
Tel (800) 545-7685 Tel (617)-783-7600
Fax (617) 783-7666
Email [email protected]

Asia Pacific Case Center

NUCB Business School

1-3-1 Nishiki Naka
Nagoya Aichi, Japan 460-0003
Tel +81 52 20 38 111
Email [email protected]


Research Information & Knowledge Hub for additional information on IMD publications

Discover our latest research
IMD's faculty and research teams publish articles, case studies, books and reports on a wide range of topics